Caxton Associates (New York)’s Affimed AFMD Stock Holding History
Bought
Maintained
Sold
Other funds holding AFMD
6CM
BBA
NMC
GPSPJS
EP
Caxton Associates (New York)'s AFMD Position: Q1 2023 in Review
Caxton Associates (New York) sold out of Affimed (AFMD) in Q1 2023, closing a stake of 8,907 shares — an estimated $110K sold.
Caxton Associates (New York) first reported a position in AFMD in Q2 2022 and held it in 3 quarters. The position peaked at $166K in Q3 2022. 94 funds tracked by Wall St. Rank hold AFMD as of Q1 2023.
- Caxton Associates (New York) reported no remaining Affimed position as of Q1 2023 after selling out during the quarter.
- Caxton Associates (New York) sold 8,907 Affimed shares in Q1 2023, an estimated $110K.
- Caxton Associates (New York) first reported a position in Affimed in Q2 2022 and held it in 3 quarters.
- Caxton Associates (New York)'s Affimed position peaked at $166K in Q3 2022.
- 94 funds tracked by Wall St. Rank held Affimed as of Q1 2023.
Based on Caxton Associates (New York)'s 13F filing for Q1 2023, filed 15 May 2023.